Role of medical Thoracoscopy in the Management of Multiloculated Empyema

Kamran Khan Sumalani1, Nadeem Ahmed Rizvi2, Asif Asghar3

  • 1Department of Chest Medicine, Jinnah Postgraduate Medical Centre, Karachi, 75400, Pakistan. drkamrankn@hotmail.com.

BMC Pulmonary Medicine
|November 30, 2018
PubMed
Abstract

Insights

Rigid medical thoracoscopy under local anesthesia effectively manages complicated pleural empyema by enabling adhesion removal. This safe and efficient procedure offers a cost-effective solution, especially in resource-limited environments.

Area of Science:

  • Pulmonology
  • Thoracic Surgery
  • Medical Interventions

Background:

  • Early pleural empyema treatment involves antibiotics and thoracocentesis.
  • Complicated empyema requires adhesion removal for lung expansion.
  • Multiloculated, exudative, and fibrinopurulent empyema present management challenges.

Purpose of the Study:

  • To analyze the experience of managing complicated empyema using rigid medical thoracoscopy.
  • To explore novel management strategies for multiloculated empyema.
  • To evaluate the efficacy and safety of thoracoscopy under local anesthesia.

Main Methods:

  • A descriptive case series of 160 patients with complicated empyema.
  • Procedures performed between September 2014 and August 2016.
  • Rigid medical thoracoscopy conducted under local anesthesia; exclusion criteria included age >70, multiple organ failure, and bleeding disorders.

Main Results:

  • The study included 160 patients (67.5% male, 32.5% female), mean age 25.37 years.
  • Tuberculous empyema was diagnosed in 63.7% of patients.
  • Complete resolution was observed in 57.5% of patients, with 36.25% showing partial resolution. Persistent air leak occurred in 5.6%, and one patient expired.

Conclusions:

  • Medical thoracoscopy under local anesthesia is a safe and efficient intervention for complicated empyema.
  • The procedure is cost-effective, particularly in resource-constrained settings.
  • This approach facilitates lung expansion by addressing adhesions in complex empyema cases.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
258
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
218
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
360
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
316
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
296
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
443